Long-Acting HIV ART: Lessons From a Year of Cabenuva

Cabenuva, the first long-acting injectable drug for HIV treatment, was approved in January and is slowly rolling out to clinics and patients nationwide.
Medscape Medical News

source https://www.medscape.com/viewarticle/961921?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost